Rifino N, Aamodt AH, Wiedmann M, Kramer M, Becker J, Guey S, Acerbi F, Herve D, Bersano A(2026) Response to the Letter to the Editor: "Reaffirming Caution-The Unacceptable Vasoconstrictive Risk of CGRP-Related Therapies in Moyamoya Angiopathy" Eur J Neurol, 33(1), e70470 DOI 10.1111/ene.70470, PubMed 41508730
Engstrand H, Argren MB, Zwart JA, Tronvik E, Winsvold BS(2025) The burden of high-frequency episodic migraine and chronic migraine in the population-based PopHEAD study Cephalalgia, 45(12), 3331024251406103 DOI 10.1177/03331024251406103, PubMed 41406073
Iannone LF, Romozzi M, Russo A, Finkelstein I, Seabi D, Ahlden A, Aamodt AH, Caronna E, Pozo-Rosich P, Tronvik EA, Sundal C(2025) Combination preventive therapy with onabotulinumtoxinA and atogepant for chronic migraine: A 24-week, prospective, real-world evaluation (SYNERGY study) Cephalalgia, 45(12), 3331024251398011 DOI 10.1177/03331024251398011, PubMed 41329703